 | • レポートコード：MRC2-11QY02954 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバルビツール酸系薬物のグローバル市場について調査・分析したレポートです。種類別（超短時間作用型バルビツール酸塩、短時間作用型バルビツール酸塩、長時間作用型バルビツール酸塩、併用薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バルビツール酸系薬物の競争状況、市場シェア ・世界のバルビツール酸系薬物市場：種類別市場規模 2015年-2020年（超短時間作用型バルビツール酸塩、短時間作用型バルビツール酸塩、長時間作用型バルビツール酸塩、併用薬） ・世界のバルビツール酸系薬物市場：種類別市場規模予測 2021年-2026年（超短時間作用型バルビツール酸塩、短時間作用型バルビツール酸塩、長時間作用型バルビツール酸塩、併用薬） ・世界のバルビツール酸系薬物市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のバルビツール酸系薬物市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のバルビツール酸系薬物市場分析：米国、カナダ ・ヨーロッパのバルビツール酸系薬物市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバルビツール酸系薬物市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバルビツール酸系薬物市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバルビツール酸系薬物市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Merck、Eli Lilly、Mylan、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Bausch Health、Oak Pharmaceuticals、Meda pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user’s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.
Market Analysis and Insights: Global Barbiturate Drugs Market
The global Barbiturate Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Barbiturate Drugs Scope and Market Size
Barbiturate Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Barbiturate Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Barbiturate Drugs market is segmented into
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Segment by Application, the Barbiturate Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Barbiturate Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Barbiturate Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Barbiturate Drugs Market Share Analysis
Barbiturate Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Barbiturate Drugs business, the date to enter into the Barbiturate Drugs market, Barbiturate Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals
Meda pharmaceuticals
1 Study Coverage
1.1 Barbiturate Drugs Product Introduction
1.2 Market Segments
1.3 Key Barbiturate Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Barbiturate Drugs Market Size Growth Rate by Type
1.4.2 Ultra-Short Acting Barbiturate
1.4.3 Short-Acting Barbiturate
1.4.4 Long-Acting Barbiturate
1.4.5 Combination Drugs
1.5 Market by Application
1.5.1 Global Barbiturate Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Barbiturate Drugs Market Size, Estimates and Forecasts
2.1.1 Global Barbiturate Drugs Revenue 2015-2026
2.1.2 Global Barbiturate Drugs Sales 2015-2026
2.2 Global Barbiturate Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Barbiturate Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Barbiturate Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Barbiturate Drugs Competitor Landscape by Players
3.1 Barbiturate Drugs Sales by Manufacturers
3.1.1 Barbiturate Drugs Sales by Manufacturers (2015-2020)
3.1.2 Barbiturate Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Barbiturate Drugs Revenue by Manufacturers
3.2.1 Barbiturate Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Barbiturate Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Barbiturate Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Barbiturate Drugs Revenue in 2019
3.2.5 Global Barbiturate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Barbiturate Drugs Price by Manufacturers
3.4 Barbiturate Drugs Manufacturing Base Distribution, Product Types
3.4.1 Barbiturate Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Barbiturate Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Barbiturate Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Barbiturate Drugs Market Size by Type (2015-2020)
4.1.1 Global Barbiturate Drugs Sales by Type (2015-2020)
4.1.2 Global Barbiturate Drugs Revenue by Type (2015-2020)
4.1.3 Barbiturate Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Barbiturate Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Barbiturate Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Barbiturate Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Barbiturate Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Barbiturate Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Barbiturate Drugs Market Size by Application (2015-2020)
5.1.1 Global Barbiturate Drugs Sales by Application (2015-2020)
5.1.2 Global Barbiturate Drugs Revenue by Application (2015-2020)
5.1.3 Barbiturate Drugs Price by Application (2015-2020)
5.2 Barbiturate Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Barbiturate Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Barbiturate Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Barbiturate Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Barbiturate Drugs by Country
6.1.1 North America Barbiturate Drugs Sales by Country
6.1.2 North America Barbiturate Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Barbiturate Drugs Market Facts & Figures by Type
6.3 North America Barbiturate Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Barbiturate Drugs by Country
7.1.1 Europe Barbiturate Drugs Sales by Country
7.1.2 Europe Barbiturate Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Barbiturate Drugs Market Facts & Figures by Type
7.3 Europe Barbiturate Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Barbiturate Drugs by Region
8.1.1 Asia Pacific Barbiturate Drugs Sales by Region
8.1.2 Asia Pacific Barbiturate Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Barbiturate Drugs Market Facts & Figures by Type
8.3 Asia Pacific Barbiturate Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Barbiturate Drugs by Country
9.1.1 Latin America Barbiturate Drugs Sales by Country
9.1.2 Latin America Barbiturate Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Barbiturate Drugs Market Facts & Figures by Type
9.3 Central & South America Barbiturate Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Barbiturate Drugs by Country
10.1.1 Middle East and Africa Barbiturate Drugs Sales by Country
10.1.2 Middle East and Africa Barbiturate Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Barbiturate Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Barbiturate Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Barbiturate Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Barbiturate Drugs Products Offered
11.2.5 Merck Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Barbiturate Drugs Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description and Business Overview
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Barbiturate Drugs Products Offered
11.4.5 Mylan Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Barbiturate Drugs Products Offered
11.5.5 Sanofi Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description and Business Overview
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Barbiturate Drugs Products Offered
11.6.5 Teva Pharmaceutical Related Developments
11.7 Sumitomo Dainippon Pharma
11.7.1 Sumitomo Dainippon Pharma Corporation Information
11.7.2 Sumitomo Dainippon Pharma Description and Business Overview
11.7.3 Sumitomo Dainippon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sumitomo Dainippon Pharma Barbiturate Drugs Products Offered
11.7.5 Sumitomo Dainippon Pharma Related Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Description and Business Overview
11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bausch Health Barbiturate Drugs Products Offered
11.8.5 Bausch Health Related Developments
11.9 Oak Pharmaceuticals
11.9.1 Oak Pharmaceuticals Corporation Information
11.9.2 Oak Pharmaceuticals Description and Business Overview
11.9.3 Oak Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Oak Pharmaceuticals Barbiturate Drugs Products Offered
11.9.5 Oak Pharmaceuticals Related Developments
11.10 Meda pharmaceuticals
11.10.1 Meda pharmaceuticals Corporation Information
11.10.2 Meda pharmaceuticals Description and Business Overview
11.10.3 Meda pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Meda pharmaceuticals Barbiturate Drugs Products Offered
11.10.5 Meda pharmaceuticals Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Barbiturate Drugs Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Barbiturate Drugs Market Estimates and Projections by Region
12.1.1 Global Barbiturate Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Barbiturate Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Barbiturate Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Barbiturate Drugs Sales Forecast (2021-2026)
12.2.2 North America: Barbiturate Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Barbiturate Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Barbiturate Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Barbiturate Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Barbiturate Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Barbiturate Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Barbiturate Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Barbiturate Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Barbiturate Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Barbiturate Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Barbiturate Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Barbiturate Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Barbiturate Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Barbiturate Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Barbiturate Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Barbiturate Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Barbiturate Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Barbiturate Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Barbiturate Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Barbiturate Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Barbiturate Drugs Market Segments
Table 2. Ranking of Global Top Barbiturate Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Barbiturate Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Ultra-Short Acting Barbiturate
Table 5. Major Manufacturers of Short-Acting Barbiturate
Table 6. Major Manufacturers of Long-Acting Barbiturate
Table 7. Major Manufacturers of Combination Drugs
Table 8. Global Barbiturate Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Barbiturate Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Barbiturate Drugs Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Barbiturate Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Barbiturate Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Barbiturate Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Barbiturate Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Barbiturate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Barbiturate Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Barbiturate Drugs as of 2019)
Table 17. Barbiturate Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Barbiturate Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Barbiturate Drugs Price (2015-2020) (USD/Pcs)
Table 20. Barbiturate Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Barbiturate Drugs Product Type
Table 22. Date of International Manufacturers Enter into Barbiturate Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 25. Global Barbiturate Drugs Sales Share by Type (2015-2020)
Table 26. Global Barbiturate Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Barbiturate Drugs Revenue Share by Type (2015-2020)
Table 28. Barbiturate Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Barbiturate Drugs Sales Share by Application (2015-2020)
Table 31. North America Barbiturate Drugs Sales by Country (2015-2020) (K Pcs)
Table 32. North America Barbiturate Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Barbiturate Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Barbiturate Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 36. North America Barbiturate Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 38. North America Barbiturate Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Barbiturate Drugs Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Barbiturate Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Barbiturate Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Barbiturate Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Barbiturate Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Barbiturate Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Barbiturate Drugs Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Barbiturate Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Barbiturate Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Barbiturate Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Barbiturate Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Barbiturate Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Barbiturate Drugs Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Barbiturate Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Barbiturate Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Barbiturate Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Barbiturate Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Barbiturate Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Barbiturate Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Barbiturate Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Barbiturate Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Barbiturate Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Barbiturate Drugs Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Barbiturate Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Barbiturate Drugs Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Barbiturate Drugs Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Merck Product
Table 80. Merck Recent Development
Table 81. Eli Lilly Corporation Information
Table 82. Eli Lilly Description and Major Businesses
Table 83. Eli Lilly Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Eli Lilly Product
Table 85. Eli Lilly Recent Development
Table 86. Mylan Corporation Information
Table 87. Mylan Description and Major Businesses
Table 88. Mylan Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Mylan Product
Table 90. Mylan Recent Development
Table 91. Sanofi Corporation Information
Table 92. Sanofi Description and Major Businesses
Table 93. Sanofi Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Sanofi Product
Table 95. Sanofi Recent Development
Table 96. Teva Pharmaceutical Corporation Information
Table 97. Teva Pharmaceutical Description and Major Businesses
Table 98. Teva Pharmaceutical Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Teva Pharmaceutical Product
Table 100. Teva Pharmaceutical Recent Development
Table 101. Sumitomo Dainippon Pharma Corporation Information
Table 102. Sumitomo Dainippon Pharma Description and Major Businesses
Table 103. Sumitomo Dainippon Pharma Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Sumitomo Dainippon Pharma Product
Table 105. Sumitomo Dainippon Pharma Recent Development
Table 106. Bausch Health Corporation Information
Table 107. Bausch Health Description and Major Businesses
Table 108. Bausch Health Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Bausch Health Product
Table 110. Bausch Health Recent Development
Table 111. Oak Pharmaceuticals Corporation Information
Table 112. Oak Pharmaceuticals Description and Major Businesses
Table 113. Oak Pharmaceuticals Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Oak Pharmaceuticals Product
Table 115. Oak Pharmaceuticals Recent Development
Table 116. Meda pharmaceuticals Corporation Information
Table 117. Meda pharmaceuticals Description and Major Businesses
Table 118. Meda pharmaceuticals Barbiturate Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Meda pharmaceuticals Product
Table 120. Meda pharmaceuticals Recent Development
Table 121. Global Barbiturate Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 122. Global Barbiturate Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Barbiturate Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Barbiturate Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Barbiturate Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. North America: Barbiturate Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Barbiturate Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Europe: Barbiturate Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Barbiturate Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 130. Asia Pacific: Barbiturate Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Barbiturate Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. Latin America: Barbiturate Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Barbiturate Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Middle East and Africa: Barbiturate Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Barbiturate Drugs Players
Table 139. Barbiturate Drugs Customers List
Table 140. Barbiturate Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Barbiturate Drugs Product Picture
Figure 2. Global Barbiturate Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Ultra-Short Acting Barbiturate Product Picture
Figure 4. Short-Acting Barbiturate Product Picture
Figure 5. Long-Acting Barbiturate Product Picture
Figure 6. Combination Drugs Product Picture
Figure 7. Global Barbiturate Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Barbiturate Drugs Report Years Considered
Figure 12. Global Barbiturate Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Barbiturate Drugs Sales 2015-2026 (K Pcs)
Figure 14. Global Barbiturate Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Barbiturate Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Barbiturate Drugs Sales Market Share by Region in 2019
Figure 17. Global Barbiturate Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Barbiturate Drugs Revenue Market Share by Region in 2019
Figure 19. Global Barbiturate Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Barbiturate Drugs Revenue in 2019
Figure 21. Barbiturate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Barbiturate Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Barbiturate Drugs Sales Market Share by Type in 2019
Figure 24. Global Barbiturate Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Barbiturate Drugs Revenue Market Share by Type in 2019
Figure 26. Global Barbiturate Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Barbiturate Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Barbiturate Drugs Sales Market Share by Application in 2019
Figure 29. Global Barbiturate Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Barbiturate Drugs Revenue Market Share by Application in 2019
Figure 31. North America Barbiturate Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Barbiturate Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Barbiturate Drugs Sales Market Share by Country in 2019
Figure 34. North America Barbiturate Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Barbiturate Drugs Market Share by Type in 2019
Figure 40. North America Barbiturate Drugs Market Share by Application in 2019
Figure 41. Europe Barbiturate Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Barbiturate Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Barbiturate Drugs Sales Market Share by Country in 2019
Figure 44. Europe Barbiturate Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Barbiturate Drugs Market Share by Type in 2019
Figure 56. Europe Barbiturate Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Barbiturate Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Barbiturate Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Barbiturate Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Barbiturate Drugs Revenue Market Share by Region in 2019
Figure 61. China Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Barbiturate Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Barbiturate Drugs Market Share by Application in 2019
Figure 85. Latin America Barbiturate Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Barbiturate Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Barbiturate Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Barbiturate Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Barbiturate Drugs Market Share by Type in 2019
Figure 96. Latin America Barbiturate Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Barbiturate Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Barbiturate Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Barbiturate Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Barbiturate Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Barbiturate Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Barbiturate Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Barbiturate Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Barbiturate Drugs Market Share by Application in 2019
Figure 109. North America Barbiturate Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Barbiturate Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Barbiturate Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Barbiturate Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Barbiturate Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Barbiturate Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Barbiturate Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Barbiturate Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Barbiturate Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Barbiturate Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 長時間作用型注射剤（LAI）の世界市場（～2026年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…
- 鎮咳薬の世界市場（～2026年） Market Analysis and Insights: Global Antitussive Drugs Market The global Antitussive Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Antitussive Drugs Scope and Market Size Antitussive Drugs market is segmented b…
- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…